Intervals between long acting neuroleptics: outcome and re-admission variables.
A drug monitoring programme has evaluated flexibility in the use of treatment intervals with Depot Fluphenazine. In this large group of schizophrenics over 30% receive injections at intervals of over 3 weeks or longer, with an overall relapse rate of 24%. Analysis of the intervals reveals in those who relapse, that 20% of cases increased their interval by an average of 7 weeks. Generally, there was an increase in intervals by the patients in the second year of treatment.
D000367:Age Factors; D002908:Chronic Disease; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010359:Patient Readmission; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*; D012737:Sex Factors; D013997:Time Factors
C011825:fluphenazine depot; D005476:Fluphenazine